Industry2h ago
Eli Lilly Invests In AI Biotech Absci
Pharmaceutical giant Eli Lilly invested in AI startup Absci to develop a hair loss treatment. The partnership focuses on ABS-201, a drug designed using generative AI tools. This deal validates AI-driven protein design in clinical pipelines. It moves the technology from theoretical research into concrete drug development for consumer health.